2019

A Momentous Week for Access to Medicines

2018

Time for a Treaty? ReAct Reports on Second Consultation on Global Development & Stewardship Framework to Combat AMR

How WHO’s Internship Policy Became More Inclusive

Onze collega gaat terug naar (Utrecht Summer) School

A Week of Promise for Access to Medicines

What Role Can Civil Society Play in the European Regulatory Process?

Staff Spotlight: Evelien Colenberg

2017

Staff Spotlight: Gemma Buckland-Merrett

2016

Intern Spotlight: A Year in Review

Intern Spotlight: Huibert-Jan Joosse

Intern Spotlight: Gaby Ooms

Intern Spotlight: Linnea Celik

Intern Spotlight: Brian Tielrooij

Intern Spotlight: Anneke Johnson

November is ‘Intern Spotlight Month’ at Health Action International

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

2015

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme

2014

Student Stop AIDS National Gathering an inspiring start to Access to Medicines Week

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

World Health Assembly: HAI and ARC intervention on antimicrobial resistance, including antibiotic resistance

World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors

A new (and improved) model to regulate pharmaceutical promotion

Enhancing accountability in the medicines market: The Medicines Transparency Alliance

2011

Statement on Medicines Patent Pool

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

Conflicts of Interest and the Future of Financing for WHO.

DG Trade public hearing on the “Protection and enforcement of IPR in third countries

Foundations: Conlicts of interests and Democracy issues

Corporate funding linked to EU patient & consumer groups policy